Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 20.7% in 2022

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 3.9 billion yuan in 2022, down 20.7% year-on-year.

Meanwhile, the company posted 44 billion yuan in revenue, up 12.7% year-on-year.

At the end of the reporting period, it had 107.2 billion yuan in total assets and 53.1 billion yuan in total liabilities, with a liability-to-asset ratio of 49.5%.